1. Home
  2. ACIU vs AVNW Comparison

ACIU vs AVNW Comparison

Compare ACIU & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

N/A

Current Price

$3.10

Market Cap

213.3M

Sector

Health Care

ML Signal

N/A

Logo Aviat Networks Inc.

AVNW

Aviat Networks Inc.

N/A

Current Price

$24.79

Market Cap

275.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ACIU
AVNW
Founded
2003
2006
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
213.3M
275.0M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
ACIU
AVNW
Price
$3.10
$24.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$10.00
$34.67
AVG Volume (30 Days)
330.1K
92.8K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.45
Revenue
N/A
$243,858,000.00
Revenue This Year
N/A
$5.59
Revenue Next Year
$495.67
$7.03
P/E Ratio
N/A
$55.73
Revenue Growth
N/A
0.56
52 Week Low
$1.43
$15.84
52 Week High
$4.00
$27.02

Technical Indicators

Market Signals
Indicator
ACIU
AVNW
Relative Strength Index (RSI) 55.81 50.65
Support Level $2.57 $20.93
Resistance Level $3.92 $26.59
Average True Range (ATR) 0.20 1.02
MACD 0.05 -0.11
Stochastic Oscillator 79.88 32.77

Price Performance

Historical Comparison
ACIU
AVNW

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About AVNW Aviat Networks Inc.

Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.

Share on Social Networks: